Novel tumor growth inhibition mechanism by cell cycle regulator cdk2ap1 involves antiangiogenesis modulation

Olga Cain, Marxa L. Figueiredo

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We evaluated the effect of expressing the cell cycle regulator protein cdk2-associating protein1 (cdk2ap1) in inhibiting growth of squamous cell carcinoma (SCC). Expression of cdk2ap1 correlated with reduction in several SCC malignant cell phenotypes, including reduced angiogenesis. We observed several alterations in gene expression consistent with classical functions of cdk2ap1, including upregulation of cell cycle inhibitory genes, and an upregulation in expression of genes belonging to both intrinsic and extrinsic apoptotic cascades. Interestingly, we also uncovered a profile of gene expression and activation of signaling pathways that may suggest new tumor-suppressive functions for cdk2ap1 through downregulation of invasion/metastasis and modulation of antiangiogenesis by upregulation of the TGFβ signaling pathway. Blocking of the TGFβ1 pathway resulted in inhibition of the cdk2ap1 antiangiogenesis phenotype. In combination, these data support the role of cdk2ap1 as a tumor suppressor gene that can regulate SCC tumor growth in a cell autonomous manner through decreases in invasiveness and a non-cell autonomous manner through decreases in angiogenesis phenotypes, and these are novel phenotypes induced by cdk2ap1.

Original languageEnglish (US)
Pages (from-to)324-331
Number of pages8
JournalMicrovascular Research
Volume80
Issue number3
DOIs
StatePublished - Dec 2010
Externally publishedYes

Fingerprint

Tumors
Cell Cycle
Genes
Cells
Modulation
Phenotype
Gene expression
Squamous Cell Carcinoma
Up-Regulation
Growth
Neoplasms
Gene Expression
cdc Genes
Cell Cycle Proteins
Tumor Suppressor Genes
Chemical activation
Transcriptional Activation
Down-Regulation
Neoplasm Metastasis
Epithelial Cells

Keywords

  • Angiogenesis
  • Cdk2ap1
  • Cell cycle
  • Invasion
  • Oral cancer
  • Squamous cell carcinoma
  • TGF-beta/activin pathway

ASJC Scopus subject areas

  • Biochemistry
  • Cardiology and Cardiovascular Medicine
  • Cell Biology

Cite this

Novel tumor growth inhibition mechanism by cell cycle regulator cdk2ap1 involves antiangiogenesis modulation. / Cain, Olga; Figueiredo, Marxa L.

In: Microvascular Research, Vol. 80, No. 3, 12.2010, p. 324-331.

Research output: Contribution to journalArticle

@article{28eaf62e81564067a3497d18d20eba5d,
title = "Novel tumor growth inhibition mechanism by cell cycle regulator cdk2ap1 involves antiangiogenesis modulation",
abstract = "We evaluated the effect of expressing the cell cycle regulator protein cdk2-associating protein1 (cdk2ap1) in inhibiting growth of squamous cell carcinoma (SCC). Expression of cdk2ap1 correlated with reduction in several SCC malignant cell phenotypes, including reduced angiogenesis. We observed several alterations in gene expression consistent with classical functions of cdk2ap1, including upregulation of cell cycle inhibitory genes, and an upregulation in expression of genes belonging to both intrinsic and extrinsic apoptotic cascades. Interestingly, we also uncovered a profile of gene expression and activation of signaling pathways that may suggest new tumor-suppressive functions for cdk2ap1 through downregulation of invasion/metastasis and modulation of antiangiogenesis by upregulation of the TGFβ signaling pathway. Blocking of the TGFβ1 pathway resulted in inhibition of the cdk2ap1 antiangiogenesis phenotype. In combination, these data support the role of cdk2ap1 as a tumor suppressor gene that can regulate SCC tumor growth in a cell autonomous manner through decreases in invasiveness and a non-cell autonomous manner through decreases in angiogenesis phenotypes, and these are novel phenotypes induced by cdk2ap1.",
keywords = "Angiogenesis, Cdk2ap1, Cell cycle, Invasion, Oral cancer, Squamous cell carcinoma, TGF-beta/activin pathway",
author = "Olga Cain and Figueiredo, {Marxa L.}",
year = "2010",
month = "12",
doi = "10.1016/j.mvr.2010.06.001",
language = "English (US)",
volume = "80",
pages = "324--331",
journal = "Microvascular Research",
issn = "0026-2862",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Novel tumor growth inhibition mechanism by cell cycle regulator cdk2ap1 involves antiangiogenesis modulation

AU - Cain, Olga

AU - Figueiredo, Marxa L.

PY - 2010/12

Y1 - 2010/12

N2 - We evaluated the effect of expressing the cell cycle regulator protein cdk2-associating protein1 (cdk2ap1) in inhibiting growth of squamous cell carcinoma (SCC). Expression of cdk2ap1 correlated with reduction in several SCC malignant cell phenotypes, including reduced angiogenesis. We observed several alterations in gene expression consistent with classical functions of cdk2ap1, including upregulation of cell cycle inhibitory genes, and an upregulation in expression of genes belonging to both intrinsic and extrinsic apoptotic cascades. Interestingly, we also uncovered a profile of gene expression and activation of signaling pathways that may suggest new tumor-suppressive functions for cdk2ap1 through downregulation of invasion/metastasis and modulation of antiangiogenesis by upregulation of the TGFβ signaling pathway. Blocking of the TGFβ1 pathway resulted in inhibition of the cdk2ap1 antiangiogenesis phenotype. In combination, these data support the role of cdk2ap1 as a tumor suppressor gene that can regulate SCC tumor growth in a cell autonomous manner through decreases in invasiveness and a non-cell autonomous manner through decreases in angiogenesis phenotypes, and these are novel phenotypes induced by cdk2ap1.

AB - We evaluated the effect of expressing the cell cycle regulator protein cdk2-associating protein1 (cdk2ap1) in inhibiting growth of squamous cell carcinoma (SCC). Expression of cdk2ap1 correlated with reduction in several SCC malignant cell phenotypes, including reduced angiogenesis. We observed several alterations in gene expression consistent with classical functions of cdk2ap1, including upregulation of cell cycle inhibitory genes, and an upregulation in expression of genes belonging to both intrinsic and extrinsic apoptotic cascades. Interestingly, we also uncovered a profile of gene expression and activation of signaling pathways that may suggest new tumor-suppressive functions for cdk2ap1 through downregulation of invasion/metastasis and modulation of antiangiogenesis by upregulation of the TGFβ signaling pathway. Blocking of the TGFβ1 pathway resulted in inhibition of the cdk2ap1 antiangiogenesis phenotype. In combination, these data support the role of cdk2ap1 as a tumor suppressor gene that can regulate SCC tumor growth in a cell autonomous manner through decreases in invasiveness and a non-cell autonomous manner through decreases in angiogenesis phenotypes, and these are novel phenotypes induced by cdk2ap1.

KW - Angiogenesis

KW - Cdk2ap1

KW - Cell cycle

KW - Invasion

KW - Oral cancer

KW - Squamous cell carcinoma

KW - TGF-beta/activin pathway

UR - http://www.scopus.com/inward/record.url?scp=78249255164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78249255164&partnerID=8YFLogxK

U2 - 10.1016/j.mvr.2010.06.001

DO - 10.1016/j.mvr.2010.06.001

M3 - Article

C2 - 20541561

AN - SCOPUS:78249255164

VL - 80

SP - 324

EP - 331

JO - Microvascular Research

JF - Microvascular Research

SN - 0026-2862

IS - 3

ER -